The key objective of obtaining informed consent from a clinical trial participant is to ensure that the participant fully understands the nature and risks.
In this installment of Risk Management 360, we set the stage for discussions of specific risk mitigation strategies to come. This article explores the relationship between FDA oversight of medical...
Case Study: Medmarc Helps Global Distributor Avert $8 Million Lawsuit Smart strategy from day one helped de-escalate a potentially devastating case. EXECUTIVE SUMMARY A physician claimed he developed...
Case Study: Negligence Claim Based on Design Defect Seasoned Experts, Swift Action Led to a Defense Verdict for Medmarc Insured EXECUTIVE SUMMARY The owner of a motorized scooter carrier rack suffered...
Case Study: Medmarc Defense Team Prevails in a Case Against a Light Therapy Device Manufacturer EXECUTIVE SUMMARY The plaintiff, in this case, suffered permanent scarring from burns left by an intense...
CMO Liability: Protect Your Business From Additional Risk Part three of a three-part series on the Contract Development and Manufacturing industry and potential products liability and manufacturers...
CMO FDA Regulation: Are CMOs Regulated by the FDA? Part two of a three-part series on the Contract Development and Manufacturing industry and potential products liability and manufacturers E&O risks.
The CMO Landscape: Diversifying to Meet an Evolving Industry Part one of a three-part series on the Contract Development and Manufacturing industry and potential products liability and manufacturers...
Created by the medical technology and life sciences industry in 1979, Medmarc has grown from a small insurance program to insuring the life sciences industry. This series takes a look at the last four...
The United States is widely regarded as the most litigious country in the world―and for good reason.
